Ai Group appreciated the opportunity to make a submission to the Inquiry into workplace drug testing in Victoria.

The inquiry is investigating the legislative and regulatory framework for workplace drug testing including: the treatment of prescription medicinal cannabis compared to other prescription medications under that framework; whether the framework for occupational health and safety and workplace drug testing may be improved to benefit medicinal cannabis patients; and whether current workplace drug testing laws and procedures are discriminatory.

The submission outlines our primary concern which relates to risks of impairment. Our position is that workplace drug testing should continue in the absence of an acceptable alternative impairment test.